Glucozamina extract din Chitina

Glucozamina un component al cartilajului articular

1 Evidenta efectiva cu suplimente nutritive ca Artrita Formula Glucosamina sulfat, Condroitin sulfat si Metilsulfonilmetan (MSM) in osteoartrita.

2 Nutraceutice ca Glucosamina, Condroitina si Metilsulfonilmetan (MSM) sint agenti terapeutici in osteoartrita.

Glucozamina extract din Chitina

Glucozamina un component al cartilajului articular

Glucozamina extract din Chitina

1 Evidenta efectiva cu suplimente nutritive ca Artrita Formula Glucosamina sulfat, Condroitin sulfat si Metilsulfonilmetan (MSM) in osteoartrita

Glucozamina si Condroitina la osteoartrita: Glucozamina cu juice 3 Capsule a 500 mg pentru articulatii

Cartilajul articular cu continut de Glucozamina si Condroitina

2 Nutraceutice ca Glucosamina, Condroitina si Metilsulfonilmetan (MSM) sint agenti terapeutici in osteoartrita

Glucozamina in cura cu suplimente nutritive produse-naturale din medicina traditionala

3 Glucozamina si Condroitina cu eficenta structurala si simptomatica la osteoartrita, meta analiza

4 Glucosamina terapia pentru tratarea de osteoartrita

5 Farmacocinetica la Glucozamina cu biodisponibilitate

6 Glucosamina la osteoartrita de genunchi, medicatia este bine tolerata, sigura si efectiva

7 Glucozamina cu actiune reversibila a catabolismului cartilajului si a moleculei pro inflamatorii IL-1 prezenta in cartilaj

Catabolismul cartilajului la osteoartrita

8 Glucozamina cu proprietate condroprotectoare in vivo inhiba degradarea activitatii catabolice a condrocitelor

9 Glucozamina moduleaza condrocitele sinteza matrice si expresia genica

10 Glucozamina si Condroitina in vivo cu actiune condroprotectoare si sinergie metabolica

11 Glucozamina cu activitate terapeutica la osteoartrita, studiu randomizat dublu orb placebo controlat

12 Glucozamina in tratamentul de baza la osteoartrita, studiu randomizat dublu orb placebo controlat

13 Glucozamina cu efect benefic la progresia de osteoartrita, studiu randomizat dublu orb placebo controlat

Glucozamina si Condroitina cu efecte benefice

14 Glucozamina reduce progresia de osteoartrita la genunchi, studiu de 3 ani randomizat dublu orb placebo controlat

15 Glucozamina sulfat reduce progresia de osteoartrita la genunchi

16 Glucozamina sulfat reduce progresia de osteoartrita la femei in postmenopauza, studiu de 3 ani

17 Glucozamina reduce progresia la osteoartrita, reviu sistematic randomizat trial

18 Glucozamina in comparatie cu ibuprofen in tratamentul osteoartrita articulatiei temporomandibulare, studiu randomizat dublu orb placebo controlat

19 Glucozamina sulfat in comparatie cu ibuprofen in osteoartrita la genunchi

20 Glucozamina sulfat in comparatie cu ibuprofen la durerea articulatiei la genunchi

21 Suplimentarea cu Glucozamina la persoane cu dureri insuportabile la genunchi

Suplimentarea cu Glucozamina la persoane cu dureri insuportabile la genunchi

22 Evolutia durerilor la pacienti cu osteoartrita, scala durerilor la genunchi

23 Glucozamina reviu de folosinta in managementul de osteoartrita

24 Glucozamina la osteoartrita si bolile gastrointestinale

25 Glucozamina si Condroitina la artrita reumatoida

26 Glucozamina sulfat si Condroitina sulfat in terapia de artrita

Glucozamina sulfat si Condroitina sulfat in terapia de artrita, osteoartrita, gonartroza si coxartroza

27 Glucozamina in managementul de artroza control investigativ clinic

28 Glucozamina cu control investigativ clinic la artroza

29 Glucozamina cu eficienta si sigur in tratamentul de gonartroza

30 Condroitina in in tratamentul de gonartroza si coxartroza

31 Glucozamina sulfat in tratamentul de coloana lombara sau spondiloza

32 Condroitina cu actiune condroprotectoare

33 Distrugerea de matrice si cresterea de condrocite in urmarea unui impact al cartilajului articular

Condrocitele cartilajului articular prin solicitare se deformeaza, pentru ca dupa solicitare sa revina la forma initiala, conferindu-i proprietati elastice

34 Activitatea metabolica a condrocitelor si integritatea structurala a cartilajului articular la impact

35 Creste productia de lichid sinovial prin concentratia inalta de glucozamina sulfat

36 Glucozaminoglicani sulfatati cu sinergie promoveaza sinteza de lichid sinovial

37 Glucozamina sulfat, Condroitina si Mangan cu eficienta in menagementul de osteoartrita

38 Glucozamina sulfat in vindecarea ranilor

39 Glucozamina sub forma de gel in vindecarea ranilor fara sa lase cicatrice, previne formare de tesut cu cicatrice, foarte important la ingrijirea pielii

40 Suplimente nutritionale pe cale orala continind Glucozamina, aminoacizi, Vitamine Minerale si Antioxidanti la ingrijirea pielii cu reducerea ridurilor cu 34%, studiu preliminar

41 Glucozamina un produs natural pentru ingrijirea pielii, reda tonusul si elasticitatea pierduta

Produse naturale ca Glucozamina pentru ingrijirea pielii

42 Glucozamina reduce aparenta faciala de hiperpigmentatie

43 Imbatranirea pielii si tratament: Anti-Aging Skin Care

44 Cresterea nivelului seric de glucozaminoglicani prin administrarea orala de Condroitina

Glucozamina creste nivelul in tesuturi

45 Receptori in derma si agentii Anti-Aging

46 Nivelul de Glucozamina la persoane cu cardiopatia ischemica cu sau fara diabet tip II

47 Glucozamina la cardiopatia ischemica

48 Mucopolizaharid - Glucozaminoglicani in tratamentul de ateroscleroza

49 Glucozamina cu efect distinct de protectie in ateroscleroza

50 Condroitina indicat in bolile coronariene, reducerea leziunilor vasculare in arterile coronariene si aorta

Glucozamina reduce leziunea aterosclerotica

51 Glucozamina cu efect retard in aterogeneza prin promovarea de heparan sulfat proteoglicani

52 Relatia intre Sulfat Glucozaminoglicani si continutul de colesterol in aorta aterosclerotica umana

Glucosamina reduce colesterolul

53 Lipoproteina moduleaza subendoteliala heparan sulfat proteoglicani HSPG si procesul aterogenic

Glucosamina cu efect la macrofage

54 Expresia umana de Perlecan este un recombinat Heparan Sulfat Proteoglican (HSPG) cu 20 kDa Glucozaminoglicani

55 Glucozamina cu actiune de inhibare activari plachetare

56 Heparan Sulfat Proteoglican la modelul eperimental de diabet, Perlecan un membru al Heparan Sulfat Proteoglican la complicatiile de diabet

57 Glucozamina cu efect de control al glucozei

58 Glucozamina doza standard pentru 6 saptamini nu afecteaza rezistenta la insulina sau disfunctie endoteliala la persoane obeze

Bibliografie-Referinte: Glucozamina

Informatii din bibliografia electronica la tema: Nutritie si sanatate

1 Reginster JY, Gillot V, Bruyere O, Henrotin Y. Evidence of nutriceutical effectiveness in the treatment of osteoarthritis. Bone and Cartilage Metabolism Research Unit, CHU Centre-Ville, Policliniques L. Brull, Quai Godefroid Kurth 45 (9 ème étage), 4020 LIEGE, Liège, Belgium. Curr Rheumatol Rep. 2000 Dec;2(6):472-7.
2 Deal CL, Moskowitz RW.Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Division of Rheumatology, Case Western Reserve University School of Medicine, University Hospitals, Cleveland, Ohio, USA. Rheum Dis Clin North Am. 1999 May;25(2):379-95.
- Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized double-blind, placebo-controlled pilot study. Mil Med. 1999; 64:85-91.
3 Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Faculty of Medicine, Department of Public Health, Public Health and Epidemiology, University of Liège, Liège, Belgium. Arch Intern Med. 2003 Jul 14;163(13):1514-22.
4 Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Medicine, Community Health and Epidemiology, Queen's University, Room 2066 Etherington Hall, Queen's University, Kingston, Ontario, Canada, K7L 3N6. Cochrane Database Syst Rev. 2001;(1):CD002946.
- Zerkak D, Dougados M. The use of glucosamine therapy in osteoarthritis. Rheumatology B Department, René Descartes University, AP-HP Cochin Hospital, 27 rue du Faubourg Saint Jacques, Paris 75014, France. Curr Pain Headache Rep. 2004 Dec;8(6):507-11.
5 Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Rotta Research Laboratorium S.p.A., Monza, Italy. Arzneimittelforschung. 1993 Oct;43(10):1109-13.
- Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Clinical Pharmacology Department, Rotta Research Laboratorium/Rottapharm, Monza, Italy. Osteoarthritis Cartilage. 2005 Dec;13(12):1041-9. Epub 2005 Sep 13.
6 Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Department of Orthopedics-Evangelisches Waldkrankenhaus, Berlin, Germany. Osteoarthritis Cartilage. 1994 Mar;2(1):51-9.
7 Herrero-Beaumont G, Rovati LC, Castañeda S, Alvarez-Soria MA, Largo R. The reverse glucosamine sulfate pathway: application in knee osteoarthritis. Rheumatology Department, Joint and Bone Research Laboratory, Fundación Jiménez Díaz--Capio, Autonomous University of Madrid, Avenida Reyes Católicos 2, 28040 Madrid, Spain. Expert Opin Pharmacother. 2007 Feb;8(2):215-25.
8 Uitterlinden EJ, Jahr H, Koevoet JL, Jenniskens YM, Bierma-Zeinstra SM, Degroot J, Verhaar JA, Weinans H, van Osch GJ. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants.Erasmus MC, University Medical Center Rotterdam, Department of Orthopaedics, The Netherlands. Osteoarthritis Cartilage. 2006 Mar;14(3):250-7. Epub 2005 Nov 18.
9 Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema KJ, Elisseeff JH. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA. Osteoarthritis Cartilage. 2007 Jan;15(1):59-68. Epub 2006 Jul 18.
10 Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Division of Orthopaedic Surgery, Maricopa Medical Center, Phoenix, AZ, USA. Clin Orthop Relat Res. 2000 Dec;(381):229-40.
11 Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther. 1980;3(4):260-72.
12 Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin. 1980;7(2):110-14.
13 Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Bone and Cartilage Metabolism Research Unit (WHO Collaborating Center for Public Aspects of Osteoarticular Disorders), University of Liege, Belgium. Lancet. 2001 Jan 27;357(9252):251-6.
14 Pavelká K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Department of Medicine and Rheumatology, Charles University, Prague, Czech Republic. Arch Intern Med. 2002 Oct 14;162(18):2113-23.
15 Karel Pavelká, MD, PhD; Jindriska Gatterová, MD; Marta Olejarová, MD; Stanislav Machacek, MD; Giampaolo Giacovelli, PhD; Lucio C. Rovati, MD. Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis A 3-Year, Randomized, Placebo-Controlled, Double-blind Study. Arch Intern Med. 2002;162:2113-2123
16 Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, Gatterova J, Giacovelli G, Reginster JY. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. WHO Collaborating Center for Public Health Aspect of Osteoarticular Disorders, Liege, Belgium. Menopause. 2004 Mar-Apr;11(2):138-43.
17 Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon-Pathom, Thailand. Ann Pharmacother. 2005 Jun;39(6):1080-7. Epub 2005 Apr 26.
18 Thie NM, Prasad NG, Major PW. Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial. Orofacial Pain Clinic, Department of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. J Rheumatol. 2001 Jun;28(6):1347-55.
19 Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Rheumazentrum, Bad Abbach, Germany. Osteoarthritis Cartilage. 1994 Mar;2(1):61-9.
20 Ruane R, Griffiths P. Glucosamine therapy compared to ibuprofen for joint pain. Primary Care and Community Pharmacy, King's College London. Br J Community Nurs. 2002 Mar;7(3):148-52.
21 Braham R, Dawson B, Goodman C. The effect of glucosamine supplementation on people experiencing regular knee pain. Department of Human Movement and Exercise Science, University of Western Australia, Crawley, Western Australia 6009. Rebecca. Br J Sports Med. 2003 Feb;37(1):45-9; discussion 49.
22 Rejeski WJ, Ettinger WH Jr, Shumaker S, Heuser MD, James P, Monu J, Burns R. The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. Department of Health and Sport Science, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA. J Rheumatol. 1995 Jun;22(6):1124-9.
23 Matheson AJ, Perry CM. Glucosamine: a review of its use in the management of osteoarthritis. Adis International Limited, Auckland, New Zealand. Drugs Aging. 2003;20(14):1041-60.
24 Russell AL. Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift. Brampton Pain Clinic, Bramalea, Ontario, Canada. Med Hypotheses. 1998 Oct;51(4):347-9.
25 McAlindon T. Glucosamine and chondroitin for rheumatoid arthritis Bulletin on the Rheumatic Diseases. 2001;50(7):1-4.
26 Constantz RB. Hyaluronan, glucosamine and chondroitin sulfate: roles for therapy in arthritis In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1998.
27 Crolle G, D'Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 1980;7(2):104-9.
28 D'Ambrosio E, Casa B, Bompani R, Scali G, Scali M. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica. 1981;2(8):504-8.
29 Giordano N, Nardi P, Senesi M, Palumbo F, Battisti E, Gonnelli S, Franci B, Campagna MS, Gennari C. The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis Istituto di Patologia Speciale Medica, Università degli Studi di Siena. Clin Ter. 1996 Mar;147(3):99-105.
30 Mazieres B, Loyau G, Menkes CJ, et al. Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo [in French; English abstract]. Rev Rhum Mal Osteoartic. 1992;59:466–472.
- L'Hirondel JL. Double-blind clinical study with oral administration of chondroitin sulphate versus placebo in tibiofemoral gonarthrosis (125 patients) [in German]. Litera Rheumatol. 1992;14:77-84.
31 W-D Mund-Hoyn. Konservative behandlung von Wirbelsäulenarthrosen mit glucosaminsulphat un phenylbutazone. Therapiewoche 1980 30: 5922-8.
- Förster KK, Schmid K, Rovati LC. Efficacy of glucosamine sulfate in osteoarthritis of the lumbar spine: a placebo-controlled, randomized, double-blind study. Arthritis Rheum 2000; 43 (Suppl.): 1613.
32 Bartolucci C, Cellai L, Corradini C, Corradini D, Lamba D, Veloná I. Chondroprotective action of chondroitin sulfate. Competitive action of chondroitin sulfate on the digestion of hyaluronan by bovine testicular hyaluronidase.Institute of Structural Chemistry, Giordano Giacomello, CNR, Rome, Italy. Int J Tissue React. 1991;13(6):311-7.
- Pipitone VR. Chondroprotection with chondroitin sulfate. Department of Rheumatology, University of Bari, Italy. Drugs Exp Clin Res. 1991;17(1):3-7.
33 Jeffrey JE, Gregory DW, Aspden RM. Matrix damage and chondrocyte viability following a single impact load on articular cartilage. Department of Orthopaedics, University of Aberdeen, Foresterhill, Scotland, United Kingdom. Arch Biochem Biophys. 1995 Sep 10;322(1):87-96.
34 Borrelli J Jr, Torzilli PA, Grigiene R, Helfet DL. Effect of impact load on articular cartilage: development of an intra-articular fracture model. Department of Orthopaedic Surgery, School of Medicine, Washington University, Barnes-Jewish Hospital, St. Louis, Missouri, USA. J Orthop Trauma. 1997 Jul;11(5):319-26.
35 McCarty MF. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Nutrition 21, San Diego, CA 92109, USA.Med Hypotheses. 1998 Jun;50(6):507-10.
36 McCarty MF, Russell AL, Seed MP. Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis. NutriGuard Research, La Jolla, CA, USA. Med Hypotheses. 2000 May;54(5):798-802.
37 Das A, Jr., Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8(5):343-350.
38 McCarty MF. Glucosamine for wound healing. Nutrition 21, San Diego, CA 92109, USA. Med Hypotheses. 1996 Oct;47(4):273-5.
39 Shaunak S, Thomas S, Gianasi E, et al. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nature Biotechnology. 2004;22(8):977-984.
40 Murad H, Tabibian MP. The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study. Journal of Dermatology Treatment. 2001;12(1):47-51.
41 Bissett DL. Glucosamine: an ingredient with skin and other benefits. J Cosmet Dermatol. 2006 Dec;5(4):309-15.
42 Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol. 2007 Mar;6(1):20-6.
43 Baumann L. Skin ageing and its treatment. Department of Dermatology, University of Miami, Miami Beach, FL, USA. J Pathol. 2007 Jan;211(2):241-51.
44 Baici A, Horler D, Moser B, et al. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheum Int. 1992; 12:81-88.
45 Ghersetich I, Troiano M, De Giorgi V, Lotti T. Receptors in skin ageing and antiageing agents. Department of Dermatology, University of Florence, Via Lorenzo il Magnifico 104, 50129 Florence, Italy. Dermatol Clin. 2007 Oct;25(4):655-62.
46 Nowak A, Szczesniak L, Rychlewski T, Dylewicz P, Przywarska I. Glucosamine levels in people with ischaemic [sic] heart disease with and without type II diabetes. Pol Arch Med Wewn. 1998;100(5):419-425.
47 Olszewski AJ, Szostak WB, McCully KS. Plasma glucosamine and galactosamine in ischemic heart disease. National Institute of Food and Nutrition, Warsaw, Poland. Atherosclerosis. 1990 May;82(1-2):75-83.
48 Morrison LM, Quilligan JJ Jr, Murata K, Schjeide OA, Freeman L, Ershoff BH. Treatment of atherosclerosis with acid mucopolysaccharides. Exp Med Surg. 1967;25(1):61-71.
49 Duan W, Paka L, Pillarisetti S. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis. Cardiovascular Diabetology. 2005;4:16.
50 Morrison LM, Enrick L. Coronary heart disease: reduction of death rate by chondroitin sulfate A. Angiology. 1973; 24:269-287.
- Morrison LM, Bajwa GS, Alfin-Slater RB, Ershoff BH. Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet. Atherosclerosis. 1972; 16:105-118
51 McCarty MF. Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans. Nutrition 21, San Diego, CA 92109, USA. Med Hypotheses. 1997 Mar;48(3):245-51.
52 Hollmann J, Schmidt A, von Bassewitz DB, Buddecke E. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and atherosclerotic human aorta. Arteiosclerosis. 1989;9:154–158.
53 Pillarisetti S. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Laboratory of Translational Research, North Shore, Long Island Jewish Health System, Manhasset, NY, USA. Trends Cardiovasc Med. 2000 Feb;10(2):60-5.
54 Graham LD, Whitelock JM, Underwood PA. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains. CSIRO Molecular Science, Sydney Laboratory, North Ryde, New South Wales, 1670, Australia. lloyd. Biochem Biophys Res Commun. 1999 Mar 24;256(3):542-8.
55 Lu-Suguro JF, Hua J, Sakamoto K, Nagaoka I. Inhibitory action of glucosamine on platelet activation in guinea pigs. Inflammation Research. 2005;54(12):493-499.
56 Conde-Knape K (2001). Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab. Res. Rev. 17 (6): 412–21. doi:10.1002/dmrr.236. PMID 11757076.
57 Stumpf JL, Lin SW. Effect of glucosamine on glucose control. University of Michigan Health System and College of Pharmacy, Ann Arbor, MI 48109, USA. Ann Pharmacother. 2006 Apr;40(4):694-8. Epub 2006 Mar 28.
58 Muniyappa R, Karne RJ, Hall G, Crandon SK, Bronstein JA, Ver MR, Hortin GL, Quon MJ. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Chief, Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, 10 Center Dr., Bldg. 10, Rm. 6C-205, Bethesda, MD 20892, USA. Diabetes. 2006 Nov;55(11):3142-50.

Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.